ArticleApplied microbiology and biotechnology2026
Vibrio proteolyticus DCF12.2 postbiotic modulates intestinal metabolic and immune pathways in zebrafish.
Article in Applied microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Postbiotics have recently emerged as a promising alternative to probiotics in aquaculture due to their improved safety, stability, and ease of application; however, the biological effects of postbiotics derived from Vibrio proteolyticus remain largely unexplored. In this study, we evaluated the impact of dietary supplementation with ethanol-inactivated V. proteolyticus DCF12.2 on the intestinal microbiota composition and transcriptomic profile of zebrafish (Danio rerio). Fish were fed a control diet (CTRL group) or a diet supplemented with 1% lyophilized ethanol-inactivated V. proteolyticus DCF12.2 (VP group) for 21 days. Alpha and beta diversity analyses exhibited no significant differences in overall gut microbial composition between dietary groups, nor at the phylum or genus level. However, differential abundance analysis at the amplicon sequence variant (ASV) level identified significant differences in ASVs affiliated with the genera Aeromonas, Delftia, Ralstonia, Shewanella, and Stenotrophomonas, which were enriched in fish receiving the VP diet (p < 0.0001). Despite these ASV-level shifts, predicted microbial metabolic functions did not differ significantly between treatments. In contrast, transcriptomic analysis via Gene Set Enrichment Analysis (GSEA) detected a clear host response: a significant downregulation of the cytokine-cytokine receptor interaction pathway and the upregulation of pathways related to nutrient metabolism, oxidative phosphorylation, and cellular biosynthesis in fish fed the VP diet (adjusted p < 0.05). These results suggest that dietary supplementation with postbiotics from V. proteolyticus DCF12.2 modulates intestinal metabolic and immune pathways without inducing major restructuring of the gut microbiota composition. Collectively, these findings provide new insights into host-postbiotic interactions and support the potential application of postbiotics from V. proteolyticus DCF12.2 as functional feed additives for sustainable aquaculture. KEY POINTS: • Postbiotic diet did not alter gut microbial diversity but induced ASV-level differences • Postbiotic diet upregulated nutrient metabolism, oxidative phosphorylation, and cellular biosynthesis • Cytokine-cytokine receptor signaling was downregulated by the postbiotic diet.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.